Ability to swallow entrectinib intact
Subjects must be able to swallow whole capsule.
Ability to swallow the study drug as a whole tablet
Participant is able to swallow a tablet whole
Ability to swallow the study drugs
Ability to swallow the study drug as a whole tablet.
Patient must be able to swallow capsule or tablet
Able to swallow study drugs whole as a tablet/capsule.
Must be able to swallow ribociclib (LEE-011) tablet/capsule
Patient must be able to swallow tablet or have existing gastrostomy feeding tube to enable administration of tablet
Able to swallow the study drugs whole
Able to swallow the study drugs whole as a tablet
Able to swallow study drugs whole as a tablet/capsule
Patients who are not able to swallow the lenalidomide capsule as a whole are excluded from this study; (capsule cannot be opened, chewed, or crushed)
Capacity to swallow
Willingness and ability to swallow study drugs
Patients must be able to swallow whole capsule
Patient must be able to swallow capsule or tablet
Patients must have the ability to swallow the study drug whole as a tablet or capsule
Ability to swallow liquids
Able to swallow the study drugs whole.
Ability to swallow the study drugs whole.
Patients who are not able to swallow the lenalidomide capsule as a whole are excluded from this study (capsule cannot be opened, chewed, or crushed)
Unable to swallow a whole tablet or capsule.
Ability to swallow study drug whole as a capsule
Ability to swallow the study drugs
Able to swallow thin liquids
Subjects that are unable to swallow a tablet/pill for any reason
Subjects that are unable to swallow a tablet/pill
Patient is able to swallow a capsule
